Califf wants to create incentives for FDA commissioners to stay longer

High commissioner turnover and difficulty attracting young leaders are undermining staff stability and confidence at the US Food and Drug Administration, Commissioner Robert Califf told a Senate subcommittee hearing on the agency’s FY 2023 budget.